Talecris Biotherapeutics Announces Record Date for 2011 Annual Meeting of Shareholders
04 Marzo 2011 - 10:15PM
PR Newswire (US)
RESEARCH TRIANGLE PARK, N.C.,
March 4, 2011 /PRNewswire/ --
Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) announced
today that its Board of Directors selected March 11, 2011 as the record date for determining
stockholders entitled to vote at the 2011 Annual Meeting of
Stockholders. The annual meeting will be held on May 3, 2011 at 9:00 a.m.
Eastern Time at the Rizzo Conference Center, 150 DuBose
House Lane, Chapel Hill, North
Carolina.
About Talecris Biotherapeutics: Inspiration.
Dedication. Innovation.
Talecris Biotherapeutics is a global biotherapeutic and
biotechnology company that discovers, develops and produces
critical care treatments for people with life-threatening disorders
in a variety of therapeutic areas including immunology,
pulmonology, neurology and hemostasis. For more information, please
visit: www.talecris.com.
SOURCE Talecris Biotherapeutics Holdings Corp.
Copyright 2011 PR Newswire
Grafico Azioni Talecris Biotherapeutics Holdings Corp. (MM) (NASDAQ:TLCR)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Talecris Biotherapeutics Holdings Corp. (MM) (NASDAQ:TLCR)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Talecris Biotherapeutics Holdings Corp. (MM) (NASDAQ): 0 articoli recenti
Più Talecris Biotherapeutics Holdings Corp. (MM) Articoli Notizie